Clinical Trial Update: A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects. [Phase 1]

View source ↗

Summary

Phase 1 drug interaction study of GSK2248761 and GSK1349572 in healthy adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GSK1349572
• GSK2248761 (GSK2248761)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I | Phase 1 | Status: WITHDRAWN